who manufactures harvoni medication
The sofosbuvir/ledipasvir coformulation is being tested with and without ribavirin. In February 2014 Gilead filed for United States Food and Drug Administration (FDA) approval of ledipasvir/sofosbuvir oral treatment, without interferon and ribavirin. On October 10th, 2014 the FDA approved the combination product ledipasvir/sofosbuvir called Harvoni.